Y

Yili Chuanning Biotechnology Co Ltd
SZSE:301301

Watchlist Manager
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Watchlist
Price: 12.8 CNY -5.26% Market Closed
Market Cap: 28.5B CNY
Have any thoughts about
Yili Chuanning Biotechnology Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Yili Chuanning Biotechnology Co Ltd

Current Assets 4.1B
Cash & Short-Term Investments 916.8m
Receivables 2.1B
Other Current Assets 1B
Non-Current Assets 6.5B
Long-Term Investments 41.5m
PP&E 6.2B
Intangibles 246.8m
Other Non-Current Assets 29m
Current Liabilities 2.1B
Accounts Payable 784m
Accrued Liabilities 62.9m
Short-Term Debt 750m
Other Current Liabilities 525.4m
Non-Current Liabilities 1.2B
Long-Term Debt 1.1B
Other Non-Current Liabilities 110.8m

Balance Sheet
Yili Chuanning Biotechnology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
507
507
1 624
758
Cash
507
507
1 624
758
Short-Term Investments
0
1
1
0
Total Receivables
1 260
1 187
1 425
1 472
Accounts Receivables
830
781
878
748
Other Receivables
431
406
548
724
Inventory
1 449
1 453
1 384
1 676
Other Current Assets
99
68
93
50
Total Current Assets
3 316
3 216
4 528
3 956
PP&E Net
6 348
5 961
5 557
5 892
PP&E Gross
6 348
5 961
5 557
5 892
Accumulated Depreciation
1 973
2 468
2 988
3 506
Intangible Assets
250
272
283
258
Goodwill
1
1
1
1
Long-Term Investments
0
0
7
7
Other Long-Term Assets
5
12
15
24
Other Assets
1
1
1
1
Total Assets
9 920
N/A
9 462
-5%
10 390
+10%
10 139
-2%
Liabilities
Accounts Payable
678
671
631
717
Accrued Liabilities
26
28
62
36
Short-Term Debt
1 045
956
1 088
1 143
Current Portion of Long-Term Debt
628
875
846
541
Other Current Liabilities
23
33
81
98
Total Current Liabilities
2 401
2 563
2 707
2 536
Long-Term Debt
2 846
2 095
1 438
545
Deferred Income Tax
0
0
0
0
Minority Interest
6
6
6
13
Other Liabilities
8
26
34
84
Total Liabilities
5 260
N/A
4 690
-11%
4 186
-11%
3 178
-24%
Equity
Common Stock
2 000
2 000
2 223
2 223
Retained Earnings
229
341
752
1 486
Additional Paid In Capital
2 431
2 431
3 229
3 252
Total Equity
4 660
N/A
4 771
+2%
6 204
+30%
6 960
+12%
Total Liabilities & Equity
9 920
N/A
9 462
-5%
10 390
+10%
10 139
-2%
Shares Outstanding
Common Shares Outstanding
2 223
2 223
2 223
2 223

See Also

Discover More